Risk factors for oxygen requirement in hospitalized pregnant and postpartum women with COVID-19

被引:1
|
作者
Baptista, Fernanda Spadotto [1 ]
Paganoti, Cristiane Freitas [2 ]
Gomez, Ursula Trovato [1 ]
Peres, Stela Verzinhasse [2 ]
Malbouisson, Luiz Marcelo [3 ]
Brizot, Maria de Lourdes [3 ]
Vieira Francisco, Rossana Pulcineli [3 ]
机构
[1] Univ Sao Paulo FMUSP, Fac Med, Dept Obstet & Ginecol, Disciplina Obstet, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo HCFMUSP, Hosp Clin, Fac Med, Div Clin Obstet, Sao Paulo, SP, Brazil
[3] Univ Sao Paulo FMUSP, Fac Med, Dept Cirurgia, Disciplina Anestesiol, Sao Paulo, SP, Brazil
来源
CLINICS | 2022年 / 77卷
关键词
COVID-19; Risk factors; Pregnancy; Maternal mortality; Oxygen supply; Intensive care unit; Severe acute respiratory syndrome; PNEUMONIA; COHORT; DEATH;
D O I
10.1016/j.clinsp.2022.100072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify risk factors for Oxygen (O-2) needs in pregnant and postpartum women with COVID-19. Methods: Prospective cohort involving pregnant women hospitalized with COVID-19 from April to October 2020. The oxygen need was analyzed regarding risk factors: demographic characteristics, clinical and laboratory parameters at hospital admission, and chest Computer Tomography (CT) findings. Poisson univariate analysis was used to estimate the Relative Risk (RR) and 95% Confidence Intervals. Results: 145 patients, 80 who used and 65 who did not use O-2, were included. Body mass index >= 30, smoking, and chronic hypertension increased the risk of O-2 need by 1.86 (95% CI 1.10-3.21), 1.57 (95% CI 1.16-2.12), and 1.46 (95% CI 1.09-1.95), respectively. Patients who were hospitalized for COVID-19 and for obstetric reasons had 8.24 (95% CI 2.8-24.29) and 3.44 (95% CI 1.05-11.31) times more use of O-2 than those admitted for childbirth and abortion. Respiratory rate >= 24 breaths/min and O-2 saturation < 95% presented RR for O-2 requirements of 2.55 (1.82-3.56) and 1.68 (95% CI 1.27-2.20), respectively. Ground Glass (GG) < 50% and with GG >= 50%, the risk of O-2 use were respectively 3.41-fold and 5.33-fold higher than in patients who haven't viral pneumonia on CT. The combination of C-reactive protein >= 21 mg/L, hemoglobin < 11.0 g/dL, and lymphopenia < 1500 mm(3) on hospital admission increased the risk of O-2 use by 4.97-times. Conclusions: In obstetric patients, clinical history, laboratory, clinical and radiological parameters at admission were identified as a risk for O-2 need, selecting the population with the greatest chance of worsening.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Factors associated with vaccination against Covid-19 in pregnant and hospitalized postpartum women: A retrospective cohort study
    Pereira Silva, Marcela de Andrade
    Ribeiro, Helena Fiats
    de Oliveira, Rosana Rosseto
    Pelloso, Fernando Castilho
    Pujals, Constanza
    Pedroso, Raissa Bocchi
    de Barros Carvalho, Maria Dalva
    Pelloso, Sandra Marisa
    [J]. PLOS ONE, 2022, 17 (06):
  • [2] Factors Related to Low COVID-19 Vaccination Rate in Pregnant and Postpartum Women with and without COVID-19
    Beser, Dilek Menekse
    Hendem, Derya Uyan
    Oluklu, Deniz
    Turgut, Ezgi
    Hancerliogullari, Necati
    Ayhan, Sule Goncu
    Tekin, Ozlem Moraloglu
    Sahin, Dilek
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2023, 45 (11): : 638 - 645
  • [3] COVID-19 Vaccines Confer Protection in Hospitalized Pregnant and Postpartum Women with Severe COVID-19: A Retrospective Cohort Study
    Paganoti, Cristiane de Freitas
    da Costa, Rafaela Alkmin
    Papageorghiou, Aris T.
    Costa, Fabricio da Silva
    Quintana, Silvana Maria
    de Godoi, Luciana Graziela
    Jimenez Monroy, Nataly Adriana
    Rodrigues, Agatha Sacramento
    Vieira Francisco, Rossana Pulcineli
    [J]. VACCINES, 2022, 10 (05)
  • [4] A temporal study of Brazilian pregnant and postpartum women vulnerability for COVID-19 Characteristics, risk factors and outcomes
    Hojo-Souza, Natalia S.
    Guidoni, Daniel L.
    Silva, Cristiano M. Da
    Souza, Fernanda S. H. De
    [J]. LANCET REGIONAL HEALTH-AMERICAS, 2022, 9
  • [5] A temporal study of Brazilian pregnant and postpartum women vulnerability for COVID-19: Characteristics, risk factors and outcomes
    Hojo-Souza, Natalia S.
    Guidoni, Daniel L.
    Da Silva, Cristiano M.
    De Souza, Fernanda S. H.
    [J]. LANCET REGIONAL HEALTH-AMERICAS, 2022, 9
  • [6] Remote monitoring of pregnant and postpartum women with COVID-19
    McCabe, Meaghan
    Gerson, Kristin D.
    Hirshberg, Adi
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S553 - S554
  • [7] Impact of Gamma COVID-19 variant on the prognosis of hospitalized pregnant and postpartum women with cardiovascular disease
    Testa, Carolina Burgarelli
    de Godoi, Luciana Graziela
    Monroy, Nataly Adriana Jimenez
    Bortolotto, Maria Rita de Figueiredo Lemos
    Rodrigues, Agatha Sacramento
    Francisco, Rossana Pulcineli Vieira
    [J]. CLINICS, 2024, 79
  • [8] Characteristics and treatment of hospitalized pregnant women with COVID-19
    Sekkarie, Ahlia
    Woodruff, Rebecca
    Whitaker, Michael
    Kramer, Michael R.
    Zapata, Lauren B.
    Ellington, Sascha R.
    Meaney-Delman, Dana M.
    Pham, Huong
    Patel, Kadam
    Taylor, Christopher A.
    Chai, Shua J.
    Kawasaki, Breanna
    Meek, James
    Openo, Kyle P.
    Weigel, Andy
    Leegwater, Lauren
    Como-Sabetti, Kathryn
    Ropp, Susan L.
    Muse, Alison
    Bennett, Nancy M.
    Billing, Laurie M.
    Sutton, Melissa
    Talbot, H. Keipp
    Hill, Mary
    Havers, Fiona P.
    [J]. AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2022, 4 (06)
  • [9] Risk Factors for Severe-Critical COVID-19 in Pregnant Women
    Berumen-Lechuga, Maria Guadalupe
    Leanos-Miranda, Alfredo
    Molina-Perez, Carlos Jose
    Garcia-Cortes, Luis Rey
    Palomo-Pinon, Silvia
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [10] Characteristics, Risk Factors, and Outcomes for Pregnant and Postpartum Patients with COVID-19 Disease.
    LeMoine, Felicia
    Taylor, Kaitlyn
    Sutton, Elizabeth
    [J]. REPRODUCTIVE SCIENCES, 2021, 28 (SUPPL 1) : 311A - 311A